Stockreport

Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform

GlucoTrack, Inc.  (GCTK) 
PDF RUTHERFORD, N.J., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc.(“Glucotrack”, or the “Company”) (Nasdaq: GCTK), a medical device company focused on the design, de [Read more]